Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis.
Send us all your questions or requests, and our expert team will assist you.
The therapeutic management of vulvar cancer is a complex, multidisciplinary endeavor that balances the oncological imperative of cure with the functional imperative of preserving genitourinary and sexual integrity. The treatment strategy is strictly stage dependent and individualized, moving away from the one-size-fits-all radical surgeries of the past towards more conservative, practical approaches. The primary modality for non-metastatic vulvar cancer is surgery, often supplemented by radiation therapy and chemotherapy for advanced or high-risk disease. The modern surgical philosophy emphasizes radicality only where necessary, aiming for clear margins while sparing the clitoris and sphincters whenever oncologically safe.
For early-stage disease, the standard treatment is wide local excision or radical partial vulvectomy. This involves removing the tumor with a margin of healthy tissue, usually 1 to 2 cm, down to the deep fascia. If the depth of invasion exceeds 1mm, the inguinal lymph nodes must be assessed, usually via the Sentinel Lymph Node Biopsy technique described previously. This approach minimizes the disfigurement and psychosexual morbidity associated with the historical radical vulvectomy, which removed the entire vulva.
When the cancer has spread to the inguinal lymph nodes or invades adjacent structures, the treatment becomes multimodal. If lymph nodes are positive, particularly if there are multiple nodes or extracapsular spread, adjuvant radiation therapy is administered to the groin and pelvis to sterilize microscopic residual disease. Chemotherapy, typically using platinum-based agents or fluorouracil, acts as a radiosensitizer, enhancing the efficacy of the radiation.
For large tumors involving the urethra, anus, or rectum, chemoradiation is increasingly used as a primary treatment. This approach aims to shrink the tumor and eradicate the cancer without the need for exenterative surgery, thereby preserving sphincter function and continence. If surgery is still required after radiation, it can be more limited in scope. This organ preservation strategy represents a significant shift in the standard of care, prioritizing quality of life alongside survival.
The removal of significant vulvar tissue creates large defects that require specialized reconstruction to restore form and function. Simple closure is not always possible or advisable due to tension and the risk of wound breakdown. Reconstructive surgeons use fasciocutaneous flaps, moving skin and fascia from nearby areas, such as the thigh or gluteal region, to cover the defect. Examples include the V-Y advancement flap or the lotus petal flap. These flaps bring their own blood supply, promoting healing and providing padding for the sensitive perineal structures. The goal of reconstruction is to maintain the vaginal opening, cover the urethra, and restore a natural appearance to the vulva.
Systemic and Targeted Therapies
Modern radiation oncology employs Intensity Modulated Radiation Therapy. Unlike older techniques, IMRT uses computer-controlled linear accelerators to sculpt the radiation dose to the 3D shape of the tumor and lymph node basins. This allows high doses to be delivered to the cancer while sparing critical surrounding structures, such as the femoral heads, bladder, bowel, and healthy skin. This reduction in toxicity is crucial for minimizing long-term side effects like lymphedema, fractures, and chronic bowel issues. Brachytherapy, the placement of radioactive seeds directly into the tumor, may be used for recurrent disease or specific anatomical locations.
Surgical Innovations and Complex Management
In the setting of metastatic or incurable recurrent disease, the focus shifts to palliation. Treatment aims to control symptoms such as pain, bleeding, and odor. Palliative radiation can be very effective for shrinking painful masses or stopping hemorrhage. Systemic chemotherapy or immunotherapy can slow disease progression. Pain management is paramount, often involving a combination of opioids, nerve blocks, and adjuvant medications. The holistic care team ensures that the patient’s dignity and comfort are prioritized, addressing the physical and emotional burdens of the disease.
Send us all your questions or requests, and our expert team will assist you.
A radical partial vulvectomy is a surgery that removes the cancerous tumor and a margin of healthy tissue around it, as well as the deep tissue underneath the tumor. Unlike a total vulvectomy, it leaves the non-cancerous parts of the vulva intact, preserving as much appearance and function as possible.
Chemoradiation is the combination of chemotherapy and radiation therapy given at the same time. The chemotherapy drugs make the cancer cells more sensitive to the radiation, making the treatment more effective than radiation alone. It is often used for larger tumors or when cancer has spread to the lymph nodes to shrink the tumor and avoid extensive surgery.
Radiation to the vulva can cause skin irritation similar to a bad sunburn, swelling, fatigue, and changes in urinary or bowel habits. Long-term, it can cause the skin to become thin and less elastic, potentially leading to narrowing of the vaginal opening or sexual discomfort.
A reconstructive flap involves moving a section of skin, fat, and sometimes muscle from a nearby area, like the thigh or buttock, to cover the wound left by removing the cancer. Because the flap keeps its own blood supply, it heals better than a skin graft and provides better cushioning and cosmetic results.
Yes, immunotherapy, specifically pembrolizumab, is an option for certain patients with advanced or recurrent vulvar cancer, particularly if the tumor tests positive for the PD-L1 protein. It works by boosting the body’s own immune system to recognize and attack the cancer cells.
Your Comparison List (you must select at least 2 packages)
